Editors' picks from other sources

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Bone problems news

Show

From To
Child developmental issues
Bone mineral density below normal in children infected early with HIV

Bone mineral density was below the general population norm in US children perinatally infected with HIV and lower than in children perinatally exposed to HIV but uninfected.

Published
21 January 2013
From
International AIDS Society
Bone problems
HIV treatment interruption associated with reduced bone loss in SMART trial

People who stopped antiretroviral therapy in the SMART trial had less bone loss and lower levels of bone metabolism biomarkers than people who remained on continuous antiretroviral therapy (ART), according to a report in the January 8, 2013, advance edition of Journal of Bone Mineral Research.

Published
16 January 2013
From
HIVandHepatitis.com
Ageing and HIV
Activist discusses challenge of growing old with HIV

Old age comes faster and hits harder for those infected with HIV, a fact aging health activist Ron Swanda knows all too well.

Published
30 November 2012
From
AFP
Bone problems
Weekly alendronate improves bone density in adults taking ART

Alendronate significantly improved bone mineral density through 96 weeks of treatment in a double-blind placebo-controlled trial that enrolled adults with osteoporosis while taking antiretroviral therapy (ART).

Published
30 August 2012
From
International AIDS Society
Bone problems
High Dose Vitamin D Prevents Fractures

High doses of vitamin D prevent fractures in older people – as long as they take the substance regularly.

Published
05 July 2012
From
Medical News Today
Bone problems
Treatment Update: Bone Health

Many studies have found that some HIV-positive people tend to have bones that are not as thick or dense as they ought to be. Such bones have reduced bone mineral density, as minerals such as calcium have been removed, rendering the bones more porous and weak.

Published
28 May 2012
From
CATIE
Bone problems
Bisphosphonate Drugs Linked to Atypical Femur Fractures, but Absolute Risk is Small

Use of bisphosphonates, a class of drugs used to manage bone loss and prevent fractures, actually appears to increase the likelihood of an unusual type of femur (thigh bone) fracture, according to a retrospective analysis described in the advance online edition of Archives of Internal Medicine. Researchers emphasized, however, that the absolute risk of atypical femur breaks remains very low.

Published
28 May 2012
From
HIVandHepatitis.com
Bone problems
Zoledronate Protects HIV Positive Men against Bone Loss for at Least 5 Years

The effects of 2 annual doses of zoledronate persist for at least 5 years in HIV positive men on antiretroviral therapy (ART), according to a New Zealand study published in the March 14, 2012, advance online edition of the Journal of Clinical Endocrinology & Metabolism.

Published
11 April 2012
From
HIVandHepatitis.com
Bone problems
CROI: Switching to Tenofovir Increases Bone Turnover, Raltegravir Can Improve Bone Density

HIV positive people who substituted tenofovir (Viread) for zidovudine (AZT; Retrovir) in their antiretroviral regimen showed elevated levels of biomarkers associated with bone turnover and decreased bone mineral density (BMD), researchers reported at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) last month in Seattle.

Published
11 April 2012
From
HIVandHepatitis.com
Bone problems
Vitamin D May Improve Bone Health in Those Taking Anti-HIV Drug

A new NIH-funded study indicates that taking Vitamin D supplements can help prevent hormonal changes that lead to bone loss amongst patients taking tenofovir (Viread) for the long-term treatment of HIV.

Published
12 January 2012
From
National Institutes of Health press release
← First123Next →

Filter by country